Anti-Toxic Principles from Musa Sapientum and Moringa Oleifera Ameliorated Skin Histo-Pathology, Decreased Lipid Peroxidation and Promoted Melatonin/TNF-Alpha/p53-Mediated Apoptosis in Cadmium Chloride-Induced Carcinogenesis in Rats

Adelaja Akinlolu,Mubarak Oloduowo Ameen,Adeoye Oyetunji Oyewopo,Risikat Eniola Kadir,Precious Nwogu,Maimunah Saad,Faith Dare,Taofeeq Garuba,Musbau Abdulazeez,Department Of Chemistry, Faculty Of Physical Sciences, University Of Ilorin, Nigeria ,Department Of Anatomy, Faculty Of Basic Medical Sciences, University Of Ilorin, Nigeria ,Department Of Anatomy, Faculty Of Basic Medical Sciences, University Of Ilorin, Nigeria ,Department Of Anatomy, Faculty Of Basic Medical Sciences, University Of Ilorin, Nigeria ,Department Of Anatomy, Faculty Of Basic Medical Sciences, University Of Ilorin, Nigeria ,Department Of Anatomy, Faculty Of Basic Medical Sciences, University Of Ilorin, Nigeria ,Department Of Plant Biology, Faculty Of Life Sciences, University Of Ilorin, Nigeria

doi:10.21315/mjps2024.22.1.3

Abstract

This study evaluated anticancer potentials of Musa sapientum (MS) and Moringa oleifera (MO) in cadmium chloride (CdCl2)-induced skin and liver carcinogenesis. Musa sapientum fraction-1 (MSF1) and Moringa oleifera fraction-6 (MOF6) were extracted from MS suckers and MO leaves, respectively, using column-chromatography methods. Forty-five adult male rats were randomly divided into 11 groups (n = 5). Cancer-induction was via single intraperitoneal administration of 1.25 mg/kg CdCl2. Groups 1 and 2 received physiological saline and CdCl2 dose, respectively. Groups 3–5 received CdCl2 dose on day 1 but were post-treated on days 15–56 with 15 mg/kg MOF6, 30 mg/kg MOF6 and 10 mg/kg MSF1, respectively. Group 6 received CdCl2dose on day 1 and were post-treated on days 15– 28 with doxorubicin + cisplatin doses. Groups 7–9 received MOF6 dose and MSF1 dose, respectively (days 1–56). Groups 10 and 11 received CdCl2dose on day 1 and were posttreated with 30 mg/kg MOF6 and 10 mg/kg MSF1, respectively (days 1–56). Doxorubicin and extracts doses were administered orally. Skin histo-pathology (haematoxylin and eosin), sera melatonin and tumour necrosis factor-alpha (TNFa) (enzyme linked immunosorbent assays [ELISA]) levels were evaluated. Malondialdehyde (thiobarbituric acid assay) and p53 (ELISA) levels were evaluated in liver homogenates. Data were statistically analysed using ANOVA at p ≤ 0.05. Results showed skin histo-alterations in Group 2, compared with normal skin histology in Groups 1 and 3–11. Statistical analyses showed significant downregulation of p53, non-significant downregulations of malondialdehyde and TNFa, and non-significant upregulation of melatonin in Groups 3–11 compared with Group 2. Overall, post-treatments with MOF6 and MSF1 exhibited possible anticancer potentials of these plants extracts via degrees of amelioration of CdCl2-induced skin histo-pathology and carcinogenesis.

Full Text